07-289
Anti-acetyl-Histone H2A (Lys9) Antibody
serum, Upstate®
Synonym(e):
H2AK9Ac, Histone H2A (acetyl K9)
Größe auswählen
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 200 μL | Warenkorb auf Verfügbarkeit prüfen | € 557,00 |
Über diesen Artikel
biological source
rabbit
Quality Level
antibody form
serum
antibody product type
primary antibodies
clone
polyclonal
species reactivity
vertebrates, human
manufacturer/tradename
Upstate®
technique(s)
western blot: suitable
isotype
IgG
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
acetylation (Lys9)
General description
Immunogen
Application
Epigenetics & Nuclear Function
Histones
Biochem/physiol Actions
Physical form
Preparation Note
Analysis Note
Legal Information
Disclaimer
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| biological source rabbit | biological source rabbit | biological source rabbit | biological source rabbit |
| species reactivity vertebrates, human | species reactivity yeast, chicken, human, rat, Saccharomyces cerevisiae, mouse | species reactivity human, Saccharomyces cerevisiae | species reactivity mouse, human, rat |
| antibody form serum | antibody form serum | antibody form serum | antibody form purified immunoglobulin |
| clone polyclonal | clone polyclonal | clone polyclonal | clone polyclonal |
| shipped in dry ice | shipped in dry ice | shipped in wet ice | shipped in dry ice |
| technique(s) western blot: suitable | technique(s) ChIP: suitable, western blot: suitable | technique(s) ChIP: suitable (ChIP-seq), dot blot: suitable, immunoprecipitation (IP): suitable, western blot: suitable | technique(s) ChIP: suitable (ChIP-seq), dot blot: suitable, flow cytometry: suitable, western blot: suitable |
Still not finding the right product?
Probieren Sie unser Produkt-Auswahlhilfe, um Ihre Auswahl einzugrenzen
Lagerklasse
10 - Combustible liquids
wgk
WGK 1
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Verwandter Inhalt
Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 07-289 | 04053252369056 |